Cognios Capital’s Biogen BIIB Stock Holding History

Cognios Capital’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,025	Closed	-$1.27M	–	35
2020 Q1	$1.27M	Buy	+4,025	New	+$1.22M	0.64%	71
2018 Q1	–	Sell	-6,318	Closed	-$2.01M	–	159
2017 Q4	$2.01M	Buy	6,318 +269	+4%	+$86.3K	0.76%	77
2017 Q3	$1.89M	Buy	+6,049	New	+$1.79M	0.77%	73

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cognios Capital's BIIB Position: Q2 2020 in Review

Cognios Capital sold out of Biogen (BIIB) in Q2 2020, closing a stake of 4,025 shares — an estimated $1.27M sold.

Cognios Capital first reported a position in BIIB in Q3 2017 and held it in 3 quarters. The position peaked at $2.01M in Q4 2017. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

Cognios Capital reported no remaining Biogen position as of Q2 2020 after selling out during the quarter.
Cognios Capital sold 4,025 Biogen shares in Q2 2020, an estimated $1.27M.
Cognios Capital first reported a position in Biogen in Q3 2017 and held it in 3 quarters.
Cognios Capital's Biogen position peaked at $2.01M in Q4 2017.
1,060 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on Cognios Capital's 13F filing for Q2 2020.